Literature DB >> 9886318

A domain mutations in 65 haemophilia A families and molecular modelling of dysfunctional factor VIII proteins.

M Liu1, M E Murphy, A R Thompson.   

Abstract

A variety of mutations are found in haemophilia A families. Those with circulating, dysfunctional protein can provide insights into structural determinants of factor VIII function. A molecular model based upon the crystal structure of the homologous A domains in caeruloplasmin enables predictions of molecular consequences of mutations. To identify haemophilic mutations in coding regions for three A domains of factor VIII and predict amino acid substitutions important for coagulant cofactor function, amplified DNA fragments from 188 unrelated haemophilia A families were screened for heteroduplex formation. Exons 1-19 were examined. 65 families were positive for 58 distinct mutations (39 novel) on DNA sequencing. 12 were non-missense mutations. 38 missense mutations were found in patients that circulate or potentially circulate dysfunctional factor VIII protein and are in an A domain molecular model. Of these 38, 12 have identical residues among all known species of factors V, VIII and caeruloplasmin. These 38 mutations have been localized onto a factor VIII A domain molecular model. Of these, 19 are in coiled, 15 in beta-pleated sheet, and two each in turns and alpha-helical structures. 15 substituted residues are on the surface, nine are partially on the surface and 14 are buried within the model structure. Mutant side-chain substitutions were inserted to predict changes in surface groups or, for buried residues, potential surface areas whose structure is probably disrupted by the substitution.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9886318     DOI: 10.1046/j.1365-2141.1998.01122.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  Contribution of A1 subunit residue Q316 in thrombin-activated factor VIII to A2 subunit dissociation.

Authors:  Ernest T Parker; Pete Lollar
Journal:  Biochemistry       Date:  2007-08-04       Impact factor: 3.162

2.  Prediction of hemophilia A severity using a small-input machine-learning framework.

Authors:  Tiago J S Lopes; Ricardo Rios; Tatiane Nogueira; Rodrigo F Mello
Journal:  NPJ Syst Biol Appl       Date:  2021-05-25

3.  In silico profiling of deleterious amino acid substitutions of potential pathological importance in haemophlia A and haemophlia B.

Authors:  George Priya Doss C
Journal:  J Biomed Sci       Date:  2012-03-16       Impact factor: 8.410

4.  Six amino acid residues in a 1200 Å2 interface mediate binding of factor VIII to an IgG4κ inhibitory antibody.

Authors:  Jasper C Lin; Ruth A Ettinger; Jason T Schuman; Ai-Hong Zhang; Muhammad Wamiq-Adhami; Phuong-Cac T Nguyen; Shelley M Nakaya-Fletcher; Komal Puranik; Arthur R Thompson; Kathleen P Pratt
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

5.  Mutations in intron 1 and intron 22 inversion negative haemophilia A patients from Western India.

Authors:  Preethi S Nair; Shrimati D Shetty; S Chandrakala; Kanjaksha Ghosh
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

6.  Clustered F8 missense mutations cause hemophilia A by combined alteration of splicing and protein biosynthesis and activity.

Authors:  Irving Donadon; John H McVey; Isabella Garagiola; Alessio Branchini; Mimosa Mortarino; Flora Peyvandi; Francesco Bernardi; Mirko Pinotti
Journal:  Haematologica       Date:  2017-11-23       Impact factor: 9.941

7.  Dissection of pleiotropic effects of variants in and adjacent to F8 exon 19 and rescue of mRNA splicing and protein function.

Authors:  Silvia Lombardi; Gabriele Leo; Simone Merlin; Antonia Follenzi; John H McVey; Iva Maestri; Francesco Bernardi; Mirko Pinotti; Dario Balestra
Journal:  Am J Hum Genet       Date:  2021-07-08       Impact factor: 11.025

8.  First report of molecular diagnosis of Tunisian hemophiliacs A: identification of 8 novel causative mutations.

Authors:  Hejer Elmahmoudi; Houssein Khodjet-el-khil; Edvard Wigren; Asma Jlizi; Kaouther Zahra; Dorothé Pellechia; Christine Vinciguerra; Balkis Meddeb; Amel Ben Ammar Elggaaied; Emna Gouider
Journal:  Diagn Pathol       Date:  2012-08-10       Impact factor: 2.644

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.